The stock of Minerva Neurosciences Inc (NASDAQ:NERV) registered an increase of 2.95% in short interest. NERV’s total short interest was 1.46M shares in March as published by FINRA. Its up 2.95% from 1.42 million shares, reported previously. With 84,100 shares average volume, it will take short sellers 17 days to cover their NERV’s short positions. The short interest to Minerva Neurosciences Inc’s float is 4.47%.
The stock increased 1.10% or $0.09 during the last trading session, reaching $8.25. About 194,363 shares traded or 36.42% up from the average. Minerva Neurosciences, Inc. (NASDAQ:NERV) has risen 65.74% since March 17, 2018 and is uptrending. It has outperformed by 61.37% the S&P500.
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. The company has market cap of $321.96 million. The companyÂ’s lead product candidate includes MIN-101, a compound for the treatment of patients with schizophrenia that completed Phase IIb clinical trial. It currently has negative earnings. It also offers MIN-202, which completed Phase IIa clinical trial for treating primary insomnia, as well as completed Phase 1b used for the treatment of major depressive disorder; and MIN-117, a compound that completed Phase IIa clinical trial for the treatment of patients suffering from major depressive disorder.
More notable recent Minerva Neurosciences, Inc. (NASDAQ:NERV) news were published by: Seekingalpha.com which released: “Minerva continues rally, up 9% – Seeking Alpha” on September 20, 2018, also Nasdaq.com with their article: “J&J Submits NDA to the FDA for Depression Drug in Adults – Nasdaq” published on September 05, 2018, Seekingalpha.com published: “Minerva Delays Roluperidone Data, But Remains On Track For Transformational 2019 – Seeking Alpha” on November 08, 2018. More interesting news about Minerva Neurosciences, Inc. (NASDAQ:NERV) were released by: Seekingalpha.com and their article: “Stocks To Watch: Paint It Black – Seeking Alpha” published on November 17, 2018 as well as Fool.com‘s news article titled: “Minerva Neurosciences Inc (NERV) Q4 2018 Earnings Conference Call Transcript – The Motley Fool” with publication date: March 12, 2019.